Literature DB >> 32733106

Detection of SARS-CoV-2 in nasal swabs using MALDI-MS.

Fabiane M Nachtigall1, Alfredo Pereira2, Oleksandra S Trofymchuk3, Leonardo S Santos4.   

Abstract

Detection of SARS-CoV-2 using RT-PCR and other advanced methods can achieve high accuracy. However, their application is limited in countries that lack sufficient resources to handle large-scale testing during the COVID-19 pandemic. Here, we describe a method to detect SARS-CoV-2 in nasal swabs using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) and machine learning analysis. This approach uses equipment and expertise commonly found in clinical laboratories in developing countries. We obtained mass spectra from a total of 362 samples (211 SARS-CoV-2-positive and 151 negative by RT-PCR) without prior sample preparation from three different laboratories. We tested two feature selection methods and six machine learning approaches to identify the top performing analysis approaches and determine the accuracy of SARS-CoV-2 detection. The support vector machine model provided the highest accuracy (93.9%), with 7% false positives and 5% false negatives. Our results suggest that MALDI-MS and machine learning analysis can be used to reliably detect SARS-CoV-2 in nasal swab samples.

Entities:  

Mesh:

Year:  2020        PMID: 32733106     DOI: 10.1038/s41587-020-0644-7

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  58 in total

Review 1.  Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures.

Authors:  Gajanan Sampatrao Ghodake; Surendra Krushna Shinde; Avinash Ashok Kadam; Rijuta Ganesh Saratale; Ganesh Dattatraya Saratale; Asad Syed; Abdallah M Elgorban; Najat Marraiki; Dae-Young Kim
Journal:  Biosens Bioelectron       Date:  2021-01-04       Impact factor: 10.618

Review 2.  Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Pawana Sharma; Sarah Berhane; Susanna S van Wyk; Nicholas Nyaaba; Julie Domen; Melissa Taylor; Jane Cunningham; Clare Davenport; Sabine Dittrich; Devy Emperador; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Jan Y Verbakel; Yemisi Takwoingi; Sian Taylor-Phillips; Ann Van den Bruel; Jonathan J Deeks
Journal:  Cochrane Database Syst Rev       Date:  2022-07-22

3.  Identification of Endogenous Peptides in Nasal Swab Transport Media used in MALDI-TOF-MS Based COVID-19 Screening.

Authors:  Helen Tsai; Brett S Phinney; Gabriela Grigorean; Michelle R Salemi; Hooman H Rashidi; John Pepper; Nam K Tran
Journal:  ACS Omega       Date:  2022-05-09

4.  Proteomics-based diagnostic peptide discovery for severe fever with thrombocytopenia syndrome virus in patients.

Authors:  Sang-Yeop Lee; Hayoung Lee; Sung Ho Yun; Edmond Changkyun Park; Giwan Seo; Hye-Yeon Kim; Sangmi Jun; Nam Hoon Kim; Dongseob Tark; Ju Yeon Lee; Chang-Seop Lee; Seung Il Kim
Journal:  Clin Proteomics       Date:  2022-07-16       Impact factor: 5.000

5.  Development of a rapid and sensitive quantum dot nanobead-based double-antigen sandwich lateral flow immunoassay and its clinical performance for the detection of SARS-CoV-2 total antibodies.

Authors:  Yaofeng Zhou; Yuan Chen; Wenjuan Liu; Hao Fang; Xiangmin Li; Li Hou; Yuanjie Liu; Weihua Lai; Xiaolin Huang; Yonghua Xiong
Journal:  Sens Actuators B Chem       Date:  2021-05-21       Impact factor: 7.460

6.  RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimens.

Authors:  Matthew M Hernandez; Radhika Banu; Paras Shrestha; Armi Patel; Feng Chen; Liyong Cao; Shelcie Fabre; Jessica Tan; Heidi Lopez; Numthip Chiu; Biana Shifrin; Inessa Zapolskaya; Vanessa Flores; Pui Yiu Lee; Sergio Castañeda; Juan David Ramírez; Jeffrey Jhang; Giuliana Osorio; Melissa R Gitman; Michael D Nowak; David L Reich; Carlos Cordon-Cardo; Emilia Mia Sordillo; Alberto E Paniz-Mondolfi
Journal:  J Med Virol       Date:  2021-05-19       Impact factor: 20.693

7.  Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Sarah Berhane; Melissa Taylor; Ada Adriano; Clare Davenport; Sabine Dittrich; Devy Emperador; Yemisi Takwoingi; Jane Cunningham; Sophie Beese; Julie Domen; Janine Dretzke; Lavinia Ferrante di Ruffano; Isobel M Harris; Malcolm J Price; Sian Taylor-Phillips; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2021-03-24

8.  A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2.

Authors:  Eduardo Juscamayta-López; Faviola Valdivia; Helen Horna; David Tarazona; Liza Linares; Nancy Rojas; Maribel Huaringa
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

9.  Mass spectrometry and machine learning for the accurate diagnosis of benzylpenicillin and multidrug resistance of Staphylococcus aureus in bovine mastitis.

Authors:  Necati Esener; Alexandre Maciel-Guerra; Katharina Giebel; Daniel Lea; Martin J Green; Andrew J Bradley; Tania Dottorini
Journal:  PLoS Comput Biol       Date:  2021-06-11       Impact factor: 4.475

10.  Infrared Based Saliva Screening Test for COVID-19.

Authors:  Bayden R Wood; Kamila Kochan; Diana E Bedolla; Natalia Salazar-Quiroz; Samantha L Grimley; David Perez-Guaita; Matthew J Baker; Jitraporn Vongsvivut; Mark J Tobin; Keith R Bambery; Dale Christensen; Shivani Pasricha; Anthony K Eden; Aaron Mclean; Supti Roy; Jason A Roberts; Julian Druce; Deborah A Williamson; Julie McAuley; Mike Catton; Damian F J Purcell; Dale I Godfrey; Philip Heraud
Journal:  Angew Chem Int Ed Engl       Date:  2021-06-29       Impact factor: 16.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.